Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4)

基因减少的二肽基肽酶 4 (DPP4) 对心脏代谢的影响

基本信息

  • 批准号:
    9892612
  • 负责人:
  • 金额:
    $ 16.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ ABSTRACT Cardiovascular disease is the leading cause of morbidity and mortality for patients with type 2 diabetes (T2DM). Determining cardiovascular effects of T2DM therapies is of clinical importance. Human genetics may be a strategy to provide insights to long-term effects of T2DM therapies and mechanisms linking T2DM and cardiovascular risk. Dipeptidyl peptidase 4 (DPP4) inhibitors are used for the treatment of T2DM and decrease degradation of substrates with possible metabolic or cardiovascular effects such as glucagon like peptide-1 (GLP-1), neuropeptides, CXCL12, brain natriuretic peptide, and substance P. Although they have the benefit of improving glucose dynamics through GLP-1 effects, DPP4 inhibitors are also associated with increased risk of hospitalization for heart failure (such as during saxagliptin), potentially related to negative effects of neuropeptides, CXCL12, and substance P. Long-term data on cardiovascular effects of DPP4 inhibition remain limited as the longest cardiovascular outcomes trial of DPP4 inhibitors was only three years. Our preliminary data in among individuals in the Penn Medicine Biobank show that on gene burden analysis for rare loss of function variants, DPP4 loss of function was significantly associated with heart failure. Phenotyping individuals with DPP4 loss of function will provide further insights as to the possible mechanism for this finding and long- term effects of decreased DPP4 activity and antigen in humans. We hypothesize that genetic DPP4 loss of function will be associated with improved metabolic parameters but also with heart failure and related biomarkers/ imaging. We will identify individuals in the Penn Medicine Biobank with DPP4 loss of function variants and their matched controls and recruit them for a phenotyping study. We will also enroll participants in a pilot clinical trial to assess the response of individuals heterozygous for DPP4 loss of function to pharmacologic DPP4 inhibition. The candidate has a strong multi-disciplinary mentoring team with experts in patient oriented research, genetics, endocrinology, cardiology (advanced heart failure), mathematical modeling/ biostatistics, and metabolomics/ proteomics. The candidate will gain necessary skills and expertise during the award period in the areas of: genetics, a genetic-based approach to clinical trials recruitment, mathematical modeling of insulin sensitivity and insulin secretion, advanced biostatistics, and leadership skills. This will facilitate the candidate achieving necessary milestones to become an independent academic physician-scientist specializing in the use of genetics and clinical trials approaches to answer questions in T2DM and metabolism, cardiovascular risk, and related therapies.
项目概要/摘要 心血管疾病是2型糖尿病患者发病和死亡的主要原因 (T2DM)。确定 T2DM 治疗对心血管的影响具有重要的临床意义。人类遗传学可能 是一种策略,可以深入了解 T2DM 治疗的长期影响以及 T2DM 与 T2DM 之间的联系机制 心血管风险。二肽基肽酶 4 (DPP4) 抑制剂用于治疗 T2DM 并减少 可能具有代谢或心血管效应的底物降解,例如胰高血糖素样肽-1 (GLP-1)、神经肽、CXCL12、脑钠肽和 P 物质。虽然它们具有以下优点: 通过 GLP-1 效应改善血糖动态,DPP4 抑制剂也与增加的风险相关 因心力衰竭住院(例如沙格列汀治疗期间),可能与以下药物的负面影响有关 神经肽、CXCL12 和 P 物质。DPP4 抑制对心血管影响的长期数据仍然存在 由于 DPP4 抑制剂最长的心血管结局试验只有三年,因此该研究受到限制。我们的初步 宾夕法尼亚大学医学生物库中个体的数据显示,对罕见损失的基因负荷分析 功能变异,DPP4 功能丧失与心力衰竭显着相关。对个体进行表型分析 DPP4 功能丧失将为这一发现的可能机制提供进一步的见解,并且长期研究 DPP4 活性和抗原降低对人类的长期影响。 我们假设遗传性 DPP4 功能丧失与代谢改善有关 参数,还包括心力衰竭和相关生物标志物/成像。我们将识别宾夕法尼亚州的个人 具有 DPP4 功能缺失变体的医学生物库及其匹配的对照,并招募它们进行 表型研究。我们还将招募参与者参加试点临床试验,以评估个人的反应 DPP4 杂合子导致药物 DPP4 抑制功能丧失。 候选人拥有强大的多学科指导团队,其中包括以患者为导向的研究专家, 遗传学、内分泌学、心脏病学(晚期心力衰竭)、数学建模/生物统计学,以及 代谢组学/蛋白质组学。候选人将在颁奖期间获得必要的技能和专业知识 领域:遗传学、基于遗传的临床试验招募方法、胰岛素的数学模型 敏感性和胰岛素分泌、先进的生物统计学和领导技能。这将有利于候选人 实现必要的里程碑,成为一名专门从事以下领域的独立学术医师科学家 使用遗传学和临床试验方法来回答 T2DM 和代谢、心血管等方面的问题 风险和相关治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Rose Wilson其他文献

Jessica Rose Wilson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Rose Wilson', 18)}}的其他基金

Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4)
基因减少的二肽基肽酶 4 (DPP4) 对心脏代谢的影响
  • 批准号:
    10631680
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)
基因减少的二肽基肽酶 4 (DPP4) 对心脏代谢的影响(来自 UPENN 的资助)
  • 批准号:
    10548188
  • 财政年份:
    2020
  • 资助金额:
    $ 16.19万
  • 项目类别:
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)
基因减少的二肽基肽酶 4 (DPP4) 对心脏代谢的影响(来自 UPENN 的资助)
  • 批准号:
    10331808
  • 财政年份:
    2020
  • 资助金额:
    $ 16.19万
  • 项目类别:
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)
基因减少的二肽基肽酶 4 (DPP4) 对心脏代谢的影响(来自 UPENN 的资助)
  • 批准号:
    10454568
  • 财政年份:
    2020
  • 资助金额:
    $ 16.19万
  • 项目类别:

相似海外基金

Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening among Rural Screening Age-Eligible Adults
制定年轻人介导的干预措施,以增加农村符合筛查年龄的成年人的结直肠癌筛查
  • 批准号:
    10653464
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Doctoral Dissertation Research: Estimating adult age-at-death from the pelvis
博士论文研究:从骨盆估算成人死亡年龄
  • 批准号:
    2316108
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
Determining age dependent factors driving COVID-19 disease severity using experimental human paediatric and adult models of SARS-CoV-2 infection
使用 SARS-CoV-2 感染的实验性人类儿童和成人模型确定导致 COVID-19 疾病严重程度的年龄依赖因素
  • 批准号:
    BB/V006738/1
  • 财政年份:
    2020
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Research Grant
Transplantation of Adult, Tissue-Specific RPE Stem Cells for Non-exudative Age-related macular degeneration (AMD)
成人组织特异性 RPE 干细胞移植治疗非渗出性年龄相关性黄斑变性 (AMD)
  • 批准号:
    10294664
  • 财政年份:
    2020
  • 资助金额:
    $ 16.19万
  • 项目类别:
Sex differences in the effect of age on episodic memory-related brain function across the adult lifespan
年龄对成人一生中情景记忆相关脑功能影响的性别差异
  • 批准号:
    422882
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Operating Grants
Modelling Age- and Sex-related Changes in Gait Coordination Strategies in a Healthy Adult Population Using Principal Component Analysis
使用主成分分析对健康成年人群步态协调策略中与年龄和性别相关的变化进行建模
  • 批准号:
    430871
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Studentship Programs
Transplantation of Adult, Tissue-Specific RPE Stem Cells as Therapy for Non-exudative Age-Related Macular Degeneration AMD
成人组织特异性 RPE 干细胞移植治疗非渗出性年龄相关性黄斑变性 AMD
  • 批准号:
    9811094
  • 财政年份:
    2019
  • 资助金额:
    $ 16.19万
  • 项目类别:
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Doctoral Dissertation Research: Literacy Effects on Language Acquisition and Sentence Processing in Adult L1 and School-Age Heritage Speakers of Spanish
博士论文研究:识字对西班牙语成人母语和学龄传统使用者语言习得和句子处理的影响
  • 批准号:
    1823881
  • 财政年份:
    2018
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
Adult Age-differences in Auditory Selective Attention: The Interplay of Norepinephrine and Rhythmic Neural Activity
成人听觉选择性注意的年龄差异:去甲肾上腺素与节律神经活动的相互作用
  • 批准号:
    369385245
  • 财政年份:
    2017
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了